Vicplas Intl（569）年報查詢
VICPLAS INTERNATIONAL LTD・新加坡交易所主板上市，SSIC 原生分類為Manufacturing（新加坡標準行業分類，無官方中文版）。本頁收錄該公司歷年年報與相關報告，PDF 由新加坡交易所（SGX）直接提供。
基本資料
Vicplas Intl 是做什麼的
Vicplas International Ltd is an investment holding company. The Vicplas Group has two core businesses - 1) The design, development and manufacture of sterile and non-sterile medical devices through our wholly-owned subsidiaries, Forefront Medical Technology (Pte) Ltd and Forefront Medical Investment Pte Ltd in Singapore; Forefront (Xiamen) Medical Devices Co., Ltd and Forefront Medical Technology (Jiangsu) Co., Ltd in China; and 81% owned subsidiary, XentiQ (Pte) Ltd. in Singapore. The wholly-owned subsidiaries are registered under the United States Food and Drug Administration (FDA) as a "contract manufacturer for medical devices"; and 2) The manufacture and distribution of piping systems for diverse industries including waste and potable water systems for residential homes, schools, commercial and industrial buildings; underground electrical and internal building wire piping systems; and data and signal line piping systems by telecommunications companies, through our wholly-owned subsidiaries, Vicplas Holdings Pte Ltd in Singapore and Rimplas Industries Sdn. Bhd. in Malaysia.
Vicplas Intl 歷年年報與報告
關於 Vicplas Intl 年報
Vicplas Intl（569）年報去哪裡下載？
本頁每個年度都附有 PDF 連結，檔案直接來自新加坡交易所（SGX）的公司公告系統。目前收錄 11 份年報，年度涵蓋 2015 至 2025。
新加坡上市公司要不要出季報？
2020 年起 SGX 取消了強制季報，改為以風險為基礎——只有特定情況的公司才須刊發季度財務報告。所以多數新加坡公司一年只有半年度報告與年報兩份定期報告，本站收錄的季報數量因此偏少，那是制度使然不是資料缺漏。
什麼是永續報告書？
SGX 自 2016 年起要求上市公司刊發永續報告（Sustainability Report），揭露環境、社會與治理（ESG）事項。它與年報是分開的兩份文件，本站兩種都收。
主板和凱利板有什麼不同？
凱利板（Catalist）門檻較低、面向成長期的中小型企業，由保薦人（sponsor）制度監督；主板（Mainboard）則有較高的獲利與市值要求。兩者的年報揭露義務相近。